文献速递泌尿系结石

Break Wave 碎石术治疗泌尿系结石:首次人体国际多中心临床试验结果

Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial.
PubMed 文献 · J Urol · 2024-09-10

这项前瞻性、多中心、单臂临床试验使用 SonoMotion Break Wave 碎石术(BWL)设备治疗泌尿系结石患者44例,单次治疗30分钟、峰值负压4.5至8 MPa。结石碎裂率88%,49%完全无石,无严重不良事件;确定最佳治疗参数后36例患者碎石率92%、58%完全无石。

要点

  • BWL单次30分钟治疗泌尿系结石,结石碎裂率88%,49%完全无石。
  • 无严重不良事件,86%患者未用或仅用少量镇痛药。
  • 最佳参数后36例碎石率92%、58%完全无石;下极结石效果较差。

核心结论

  • BWL提供了安全有效的非侵入性结石治疗,几乎不需要麻醉,并可在非手术环境中成功实施。

研究设计与样本

  • 前瞻性、多中心、单臂临床试验,使用SonoMotion(美国加州圣马特奥)Break Wave碎石术(BWL)设备。
  • 44例输尿管结石(43%)或肾结石(57%)患者,来自5个中心,接受单次30分钟治疗,峰值负压4.5至8 MPa。
  • 治疗后第7、14、35天评估结局,术后70±14天进行临床随访和CT成像。
  • 主要目标为评估安全性(血肿、并发症等)和有效性(任何碎裂、残留碎片≤4 mm或≤2 mm、完全无石率),通过非增强CT(肾、输尿管、膀胱)评估。

主要发现

  • 结石碎裂发生于88%的病例;70%有≤4 mm碎片,51%有≤2 mm碎片,49%在CT上完全无石;未报告严重不良事件。
  • 86%的患者接受未用镇痛药(50%)或仅用少量镇痛药(36%)。
  • 确定最佳治疗参数后,36例患者接受治疗,有效性改善:碎石率92%(33/36),残留碎片≤4 mm为75%,≤2 mm为58%,完全无石58%。
  • 下极结石患者有效性较低:碎石率81%,≤4 mm碎片71%,≤2 mm碎片29%,完全无石29%;远端输尿管结石患者中89%完全无石。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study reports on a prospective, multicenter, single-arm, clinical trial utilizing the SonoMotion (San Mateo, California) Break Wave lithotripsy (BWL) device to fragment urinary stones. MATERIALS AND METHODS: Patients with a urinary stone underwent a single treatment of 30 minutes and peak negative pressure of 4.5 to 8 MPa. Subjects were contacted and outcomes assessed at 7, 14, and 35 days after treatment, with clinical follow-up and CT imaging 70 ± 14 days postprocedure. The primary objectives were to assess the safety (hematomas, complications, etc) and effectiveness of BWL (any fragmentation, residual fragments ≤4 mm or ≤2 mm, and completely stone-free rate) as assessed via noncontrast CT-kidneys, ureters, and bladder. RESULTS: Forty-four patients with a ureteral (43%) or renal (57%) stone were treated across 5 centers. Stone fragmentation occurred in 88% of cases; 70% had fragments ≤ 4 and 51% ≤ 2 mm, while 49% were completely stone free on CT; no serious adverse events were reported. Eighty-six percent of patients received either no analgesic medication at all (50%) or minor analgesia (36%). After determining optimal therapy settings, 36 patients were treated and the effectiveness improved exhibiting fragmentation in 92% (33/36), residual fragments ≤ 4 mm in 75% and 58% with fragments ≤ 2 mm with 58% completely stone free. Effectiveness was less in subjects with lower pole stones with 81% fragmentation, 71% having fragments ≤ 4 mm, 29% with fragments ≤ 2 mm, and 29% completely stone free; of distal ureteral stone patients, 89% were completely stone free. CONCLUSIONS: BWL offered safe and effective noninvasive stone therapy requiring little to no anesthesia and was carried out successfully in nonoperative environments. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT03811171.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Chew BH, Harper JD, Sur RL, et al. Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial. J Urol. 2024. PMID: 39254129. doi:10.1097/JU.0000000000004091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。